This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Ruprecht-Karls-Universitat Heidelberg, Biocrates Life Sciences Ag, Deutsches Krebsforsch. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 64 
1 out of 6 
1 out of 1 
Years Active: 2017-2022
Title: Barbara Burwinkel: A Pioneer in Biomarker Research and Nucleic Acid Synthesis
Introduction
Barbara Burwinkel, an innovative scientist based in Heidelberg, Germany, has made significant contributions in the fields of oncology and molecular biology. With a remarkable portfolio of 5 patents, she has established herself as a leader in research aimed at improving the diagnosis and understanding of various diseases, particularly ovarian cancer.
Latest Patents
Among her latest achievements, Burwinkel developed a patent for a metabolic biomarker set that enhances the assessment of ovarian cancer. This invention focuses on new biomarkers that are particularly sensitive in identifying the disease at its early stages. Additionally, her patent for the synthesis of double-stranded nucleic acids presents a method for creating these nucleic acids from a diverse array of samples, which can be utilized in deep sequence analysis. This patent also includes specific reagents essential for the synthesis process and kits designed for effective implementation of the method.
Career Highlights
Throughout her career, Barbara has worked with prestigious institutions including Ruprecht-Karls-University Heidelberg and the German Cancer Research Center (Deutsches Krebsforschungszentrum). Her academic and research endeavors have focused on solving critical challenges in cancer diagnostics and treatment.
Collaborations
In her pursuit of innovation, Burwinkel has collaborated with accomplished colleagues such as Dharanija Madhavan and Andrey Turchinovich. These partnerships have enhanced her research capabilities and led to advancements in her field of expertise.
Conclusion
Barbara Burwinkel stands out as a prominent figure in the realm of biomedical research. Her inventions, particularly in the detection of ovarian cancer and the synthesis of nucleic acids, reflect her commitment to advancing medical science. As she continues to break new ground in her studies, her work serves as an inspiration to aspiring innovators in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile